Share

June 2022; 12 (3) Five New Things

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Five New Things

Chafic Karam
First published January 27, 2022, DOI: https://doi.org/10.1212/CPJ.0000000000001150
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
814

Share

Article Information

vol. 12 no. 3 258-262
DOI: 
https://doi.org/10.1212/CPJ.0000000000001150
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received September 23, 2021
  • Accepted December 10, 2021
  • First Published January 27, 2022.

Article Versions

Copyright & Usage: 
© 2022 American Academy of Neurology

Author Disclosures

    1. Chafic Karam, MD
  1. Chafic Karam, MD
    2. Scientific Advisory Boards:

    1. I served on DMSB for a Phase 2/3 Trial of Arimoclomol in Inclusion Body Myositis (IBM)

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. I have received speaker honoraria from Akcea, Alnylam,Biogen, Genzyme and CSL behring.

    Editorial Boards:

    1. I served on the editorial board of the Neurology Resident and Fellow section. I served as Deputy Editor, Neurology Write Click, Dispute and Debate.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. I have received consulting honoraria from Akcea, Alnylam, Alexion, Biogen, Cytokinetics, Genzyme and CSL Behring.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Neurology, University of Pennsylvania, Philadelphia.
  1. Correspondence
    Dr. Karam chafic.karam{at}pennmedicine.upenn.edu
View Full Text

Article usage

Article usage: January 2022 to July 2022

AbstractFullPdfSource
Jan 2022230019Highwire
Feb 202226380415Highwire
Mar 2022375056Highwire
Apr 2022283038Highwire
May 2022203016Highwire
Jun 20222193303198Highwire
Jul 202213869372Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me